View Cart  

QRxPharma Announces Strategic Collaboration With Paladin Labs

A A
QRxPharma announced execution of a licensing agreement with Paladin Labs for the Canadian commercialization rights to MOXDUO, a patented, immediate release formulation of morphine and oxycodone.
The Herald